CN108635572A - It is a kind of to treat otitis and the auristilla and preparation method thereof for ear function of feeling well with clear ear - Google Patents
It is a kind of to treat otitis and the auristilla and preparation method thereof for ear function of feeling well with clear ear Download PDFInfo
- Publication number
- CN108635572A CN108635572A CN201810853764.3A CN201810853764A CN108635572A CN 108635572 A CN108635572 A CN 108635572A CN 201810853764 A CN201810853764 A CN 201810853764A CN 108635572 A CN108635572 A CN 108635572A
- Authority
- CN
- China
- Prior art keywords
- ear
- specifically
- auristilla
- sodium
- extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000005141 Otitis Diseases 0.000 title claims abstract description 65
- 208000019258 ear infection Diseases 0.000 title claims abstract description 64
- APSBXTVYXVQYAB-UHFFFAOYSA-M sodium docusate Chemical compound [Na+].CCCCC(CC)COC(=O)CC(S([O-])(=O)=O)C(=O)OCC(CC)CCCC APSBXTVYXVQYAB-UHFFFAOYSA-M 0.000 title claims abstract description 32
- 238000002360 preparation method Methods 0.000 title claims abstract description 27
- 239000000284 extract Substances 0.000 claims abstract description 109
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims abstract description 62
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 54
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 44
- 229940088594 vitamin Drugs 0.000 claims abstract description 44
- 229930003231 vitamin Natural products 0.000 claims abstract description 44
- 235000013343 vitamin Nutrition 0.000 claims abstract description 44
- 239000011782 vitamin Substances 0.000 claims abstract description 44
- 231100000252 nontoxic Toxicity 0.000 claims abstract description 39
- 230000003000 nontoxic effect Effects 0.000 claims abstract description 39
- 241000411851 herbal medicine Species 0.000 claims abstract description 38
- 230000003110 anti-inflammatory effect Effects 0.000 claims abstract description 33
- 239000004615 ingredient Substances 0.000 claims abstract description 32
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims abstract description 31
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims abstract description 31
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 claims abstract description 31
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims abstract description 31
- 229960000458 allantoin Drugs 0.000 claims abstract description 31
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims abstract description 31
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims abstract description 31
- 229960000367 inositol Drugs 0.000 claims abstract description 31
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical class CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims abstract description 31
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims abstract description 31
- 230000017531 blood circulation Effects 0.000 claims abstract description 27
- 230000001737 promoting effect Effects 0.000 claims abstract description 26
- 239000000022 bacteriostatic agent Substances 0.000 claims abstract description 25
- 230000035790 physiological processes and functions Effects 0.000 claims abstract description 21
- 239000000556 agonist Substances 0.000 claims abstract description 20
- 239000005515 coenzyme Substances 0.000 claims abstract description 20
- 230000004060 metabolic process Effects 0.000 claims abstract description 20
- 150000001413 amino acids Chemical class 0.000 claims abstract description 19
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 19
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 18
- 239000000126 substance Substances 0.000 claims abstract description 6
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 60
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 51
- 239000011734 sodium Substances 0.000 claims description 51
- 229910052708 sodium Inorganic materials 0.000 claims description 51
- 239000000203 mixture Substances 0.000 claims description 50
- 235000019441 ethanol Nutrition 0.000 claims description 47
- 210000004027 cell Anatomy 0.000 claims description 41
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 claims description 40
- 235000002949 phytic acid Nutrition 0.000 claims description 40
- 235000007516 Chrysanthemum Nutrition 0.000 claims description 35
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 35
- 241000180649 Panax notoginseng Species 0.000 claims description 35
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 32
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 claims description 32
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 claims description 32
- 239000004302 potassium sorbate Substances 0.000 claims description 32
- 235000010241 potassium sorbate Nutrition 0.000 claims description 32
- 229940069338 potassium sorbate Drugs 0.000 claims description 32
- 235000011478 zinc gluconate Nutrition 0.000 claims description 32
- 239000011670 zinc gluconate Substances 0.000 claims description 32
- 229960000306 zinc gluconate Drugs 0.000 claims description 32
- 239000002253 acid Substances 0.000 claims description 30
- 239000003814 drug Substances 0.000 claims description 30
- 229930182470 glycoside Natural products 0.000 claims description 30
- 150000002338 glycosides Chemical class 0.000 claims description 30
- 239000001397 quillaja saponaria molina bark Substances 0.000 claims description 30
- 229930182490 saponin Natural products 0.000 claims description 30
- 150000007949 saponins Chemical class 0.000 claims description 30
- 229960003080 taurine Drugs 0.000 claims description 30
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 claims description 28
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims description 28
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 28
- 239000001525 mentha piperita l. herb oil Substances 0.000 claims description 28
- 229940041616 menthol Drugs 0.000 claims description 28
- 235000019477 peppermint oil Nutrition 0.000 claims description 28
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 27
- BAWFJGJZGIEFAR-NNYOXOHSSA-N NAD zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-N 0.000 claims description 26
- 229950006238 nadide Drugs 0.000 claims description 26
- 238000000034 method Methods 0.000 claims description 23
- IWHVCHNCTHGORM-UHDJGPCESA-M potassium;(e)-3-phenylprop-2-enoate Chemical compound [K+].[O-]C(=O)\C=C\C1=CC=CC=C1 IWHVCHNCTHGORM-UHDJGPCESA-M 0.000 claims description 22
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 claims description 21
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 claims description 21
- 239000001685 glycyrrhizic acid Substances 0.000 claims description 21
- 229960004949 glycyrrhizic acid Drugs 0.000 claims description 21
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 claims description 21
- 235000019410 glycyrrhizin Nutrition 0.000 claims description 21
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims description 21
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 claims description 20
- 239000000467 phytic acid Substances 0.000 claims description 20
- 229940068041 phytic acid Drugs 0.000 claims description 20
- WGIWBXUNRXCYRA-UHFFFAOYSA-H trizinc;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O WGIWBXUNRXCYRA-UHFFFAOYSA-H 0.000 claims description 20
- 235000006076 zinc citrate Nutrition 0.000 claims description 20
- 239000011746 zinc citrate Substances 0.000 claims description 20
- 229940068475 zinc citrate Drugs 0.000 claims description 20
- 241000125175 Angelica Species 0.000 claims description 19
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 19
- CANRESZKMUPMAE-UHFFFAOYSA-L Zinc lactate Chemical compound [Zn+2].CC(O)C([O-])=O.CC(O)C([O-])=O CANRESZKMUPMAE-UHFFFAOYSA-L 0.000 claims description 19
- 239000003755 preservative agent Substances 0.000 claims description 19
- 230000002335 preservative effect Effects 0.000 claims description 19
- 229940050168 zinc lactate Drugs 0.000 claims description 19
- 235000000193 zinc lactate Nutrition 0.000 claims description 19
- 239000011576 zinc lactate Substances 0.000 claims description 19
- 235000001014 amino acid Nutrition 0.000 claims description 18
- 229940024606 amino acid Drugs 0.000 claims description 18
- 230000001413 cellular effect Effects 0.000 claims description 18
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims description 17
- 235000013922 glutamic acid Nutrition 0.000 claims description 17
- 239000004220 glutamic acid Substances 0.000 claims description 17
- 238000002156 mixing Methods 0.000 claims description 17
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims description 16
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 16
- 229960002685 biotin Drugs 0.000 claims description 16
- 235000020958 biotin Nutrition 0.000 claims description 16
- 239000011616 biotin Substances 0.000 claims description 16
- 229960003966 nicotinamide Drugs 0.000 claims description 16
- 235000005152 nicotinamide Nutrition 0.000 claims description 16
- 239000011570 nicotinamide Substances 0.000 claims description 16
- 229960003512 nicotinic acid Drugs 0.000 claims description 16
- 235000001968 nicotinic acid Nutrition 0.000 claims description 16
- 239000011664 nicotinic acid Substances 0.000 claims description 16
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 15
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 claims description 15
- 239000000463 material Substances 0.000 claims description 15
- 230000008569 process Effects 0.000 claims description 15
- 241000213006 Angelica dahurica Species 0.000 claims description 14
- 239000004475 Arginine Substances 0.000 claims description 14
- 239000004471 Glycine Substances 0.000 claims description 14
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 14
- 238000001914 filtration Methods 0.000 claims description 14
- 235000015424 sodium Nutrition 0.000 claims description 14
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 claims description 13
- 239000002904 solvent Substances 0.000 claims description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 claims description 12
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims description 12
- 235000011088 sodium lactate Nutrition 0.000 claims description 12
- 239000001540 sodium lactate Substances 0.000 claims description 12
- 229940005581 sodium lactate Drugs 0.000 claims description 12
- 235000013339 cereals Nutrition 0.000 claims description 10
- 239000004310 lactic acid Substances 0.000 claims description 10
- 235000014655 lactic acid Nutrition 0.000 claims description 10
- 241000723353 Chrysanthemum Species 0.000 claims description 9
- 239000012535 impurity Substances 0.000 claims description 9
- JXKPEJDQGNYQSM-UHFFFAOYSA-M sodium propionate Chemical compound [Na+].CCC([O-])=O JXKPEJDQGNYQSM-UHFFFAOYSA-M 0.000 claims description 9
- 239000004324 sodium propionate Substances 0.000 claims description 9
- 235000010334 sodium propionate Nutrition 0.000 claims description 9
- 229960003212 sodium propionate Drugs 0.000 claims description 9
- 238000009472 formulation Methods 0.000 claims description 7
- 210000000056 organ Anatomy 0.000 claims description 7
- 238000006243 chemical reaction Methods 0.000 claims description 6
- 210000000613 ear canal Anatomy 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- 238000005303 weighing Methods 0.000 claims description 6
- 240000008027 Akebia quinata Species 0.000 claims description 5
- 235000007756 Akebia quinata Nutrition 0.000 claims description 5
- 241000205585 Aquilegia canadensis Species 0.000 claims description 5
- 241000928504 Centipeda minima Species 0.000 claims description 5
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims description 5
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 5
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims description 5
- 239000009636 Huang Qi Substances 0.000 claims description 5
- 244000246386 Mentha pulegium Species 0.000 claims description 5
- 235000016257 Mentha pulegium Nutrition 0.000 claims description 5
- 235000004357 Mentha x piperita Nutrition 0.000 claims description 5
- 240000007594 Oryza sativa Species 0.000 claims description 5
- 235000007164 Oryza sativa Nutrition 0.000 claims description 5
- 244000046146 Pueraria lobata Species 0.000 claims description 5
- 235000010575 Pueraria lobata Nutrition 0.000 claims description 5
- 241000951473 Schizonepeta Species 0.000 claims description 5
- SNGZVXPRGLTKNU-RGMNGODLSA-N [Na].C(CC)N[C@@H](CCO)C(=O)O Chemical compound [Na].C(CC)N[C@@H](CCO)C(=O)O SNGZVXPRGLTKNU-RGMNGODLSA-N 0.000 claims description 5
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 claims description 5
- -1 glycitols compound Chemical class 0.000 claims description 5
- 235000001050 hortel pimenta Nutrition 0.000 claims description 5
- 229940010454 licorice Drugs 0.000 claims description 5
- 235000013923 monosodium glutamate Nutrition 0.000 claims description 5
- 239000002245 particle Substances 0.000 claims description 5
- 235000009566 rice Nutrition 0.000 claims description 5
- 229940073490 sodium glutamate Drugs 0.000 claims description 5
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 claims description 4
- 239000012752 auxiliary agent Substances 0.000 claims description 4
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 claims description 4
- 238000000605 extraction Methods 0.000 claims description 4
- 150000001875 compounds Chemical class 0.000 claims description 3
- 235000009508 confectionery Nutrition 0.000 claims description 3
- 210000000481 breast Anatomy 0.000 claims description 2
- 210000005056 cell body Anatomy 0.000 claims description 2
- 150000003891 oxalate salts Chemical class 0.000 claims description 2
- 235000006708 antioxidants Nutrition 0.000 claims 4
- 240000004670 Glycyrrhiza echinata Species 0.000 claims 1
- 229910052737 gold Inorganic materials 0.000 claims 1
- 239000010931 gold Substances 0.000 claims 1
- 229910052738 indium Inorganic materials 0.000 claims 1
- 208000009205 Tinnitus Diseases 0.000 abstract description 15
- 230000036541 health Effects 0.000 abstract description 15
- 231100000886 tinnitus Toxicity 0.000 abstract description 15
- 210000004556 brain Anatomy 0.000 abstract description 10
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 6
- 235000016709 nutrition Nutrition 0.000 abstract description 6
- 208000003251 Pruritus Diseases 0.000 abstract description 5
- 238000005516 engineering process Methods 0.000 abstract description 5
- 238000005469 granulation Methods 0.000 abstract description 5
- 230000003179 granulation Effects 0.000 abstract description 5
- 230000017074 necrotic cell death Effects 0.000 abstract description 5
- 206010002198 Anaphylactic reaction Diseases 0.000 abstract description 4
- 208000003455 anaphylaxis Diseases 0.000 abstract description 4
- 230000035764 nutrition Effects 0.000 abstract description 4
- 206010014020 Ear pain Diseases 0.000 abstract description 3
- 239000008280 blood Substances 0.000 abstract description 3
- 210000004369 blood Anatomy 0.000 abstract description 3
- 208000007176 earache Diseases 0.000 abstract description 3
- 230000007803 itching Effects 0.000 abstract description 3
- 238000012423 maintenance Methods 0.000 abstract description 2
- 239000003223 protective agent Substances 0.000 abstract 2
- 241000245240 Lonicera Species 0.000 abstract 1
- 230000002500 effect on skin Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 35
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 26
- 230000006870 function Effects 0.000 description 24
- 201000010099 disease Diseases 0.000 description 13
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 13
- 230000000149 penetrating effect Effects 0.000 description 10
- 231100000331 toxic Toxicity 0.000 description 10
- 230000002588 toxic effect Effects 0.000 description 10
- 229940079593 drug Drugs 0.000 description 8
- 208000024891 symptom Diseases 0.000 description 8
- 239000002537 cosmetic Substances 0.000 description 7
- 235000013305 food Nutrition 0.000 description 7
- 235000013402 health food Nutrition 0.000 description 7
- BQENDLAVTKRQMS-SBBGFIFASA-L Carbenoxolone sodium Chemical compound [Na+].[Na+].C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C([O-])=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](OC(=O)CCC([O-])=O)C1(C)C BQENDLAVTKRQMS-SBBGFIFASA-L 0.000 description 6
- 229960002252 carbenoxolone sodium Drugs 0.000 description 6
- 210000005069 ears Anatomy 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 6
- 206010061218 Inflammation Diseases 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 230000004054 inflammatory process Effects 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 206010067484 Adverse reaction Diseases 0.000 description 4
- 206010011878 Deafness Diseases 0.000 description 4
- 241000202807 Glycyrrhiza Species 0.000 description 4
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 4
- 230000006838 adverse reaction Effects 0.000 description 4
- 229940088710 antibiotic agent Drugs 0.000 description 4
- 230000000116 mitigating effect Effects 0.000 description 4
- 206010033072 otitis externa Diseases 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 208000025301 tympanitis Diseases 0.000 description 4
- BCZXFFBUYPCTSJ-UHFFFAOYSA-L Calcium propionate Chemical compound [Ca+2].CCC([O-])=O.CCC([O-])=O BCZXFFBUYPCTSJ-UHFFFAOYSA-L 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 206010040880 Skin irritation Diseases 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- 239000004330 calcium propionate Substances 0.000 description 3
- 235000010331 calcium propionate Nutrition 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 208000032625 disorder of ear Diseases 0.000 description 3
- 210000000959 ear middle Anatomy 0.000 description 3
- 239000003344 environmental pollutant Substances 0.000 description 3
- 229910001385 heavy metal Inorganic materials 0.000 description 3
- 229960000448 lactic acid Drugs 0.000 description 3
- 231100000719 pollutant Toxicity 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 230000036556 skin irritation Effects 0.000 description 3
- 231100000475 skin irritation Toxicity 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 2
- GSDSWSVVBLHKDQ-UHFFFAOYSA-N 9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid Chemical class FC1=CC(C(C(C(O)=O)=C2)=O)=C3N2C(C)COC3=C1N1CCN(C)CC1 GSDSWSVVBLHKDQ-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 2
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 2
- 206010033078 Otitis media Diseases 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 241000863032 Trieres Species 0.000 description 2
- HCFOYBNXMYSROO-UHFFFAOYSA-N [K].C(C=CC1=CC=CC=C1)(=O)O Chemical compound [K].C(C=CC1=CC=CC=C1)(=O)O HCFOYBNXMYSROO-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000002421 anti-septic effect Effects 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 230000000035 biogenic effect Effects 0.000 description 2
- 230000003750 conditioning effect Effects 0.000 description 2
- 210000003792 cranial nerve Anatomy 0.000 description 2
- 231100000895 deafness Toxicity 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 230000001804 emulsifying effect Effects 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 238000003912 environmental pollution Methods 0.000 description 2
- 235000004554 glutamine Nutrition 0.000 description 2
- 230000003862 health status Effects 0.000 description 2
- 208000016354 hearing loss disease Diseases 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 210000000663 muscle cell Anatomy 0.000 description 2
- 230000000474 nursing effect Effects 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 230000001151 other effect Effects 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 229940083542 sodium Drugs 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 229940074410 trehalose Drugs 0.000 description 2
- DWNBOPVKNPVNQG-LURJTMIESA-N (2s)-4-hydroxy-2-(propylamino)butanoic acid Chemical compound CCCN[C@H](C(O)=O)CCO DWNBOPVKNPVNQG-LURJTMIESA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- BHWMZEPWQUFLLQ-UHFFFAOYSA-N 2-hydroxypropanoic acid;zinc Chemical compound [Zn].CC(O)C(O)=O BHWMZEPWQUFLLQ-UHFFFAOYSA-N 0.000 description 1
- 102000004452 Arginase Human genes 0.000 description 1
- 108700024123 Arginases Proteins 0.000 description 1
- 206010050337 Cerumen impaction Diseases 0.000 description 1
- 239000003390 Chinese drug Substances 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 201000008197 Laryngitis Diseases 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 206010045210 Tympanic Membrane Perforation Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 241001148470 aerobic bacillus Species 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 239000002647 aminoglycoside antibiotic agent Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 239000010425 asbestos Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000036995 brain health Effects 0.000 description 1
- 229910052793 cadmium Inorganic materials 0.000 description 1
- RDVQTQJAUFDLFA-UHFFFAOYSA-N cadmium Chemical compound [Cd][Cd][Cd][Cd][Cd][Cd][Cd][Cd][Cd] RDVQTQJAUFDLFA-UHFFFAOYSA-N 0.000 description 1
- 210000002939 cerumen Anatomy 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 210000003477 cochlea Anatomy 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000006356 dehydrogenation reaction Methods 0.000 description 1
- 210000000883 ear external Anatomy 0.000 description 1
- 210000003027 ear inner Anatomy 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 210000002388 eustachian tube Anatomy 0.000 description 1
- 238000010579 first pass effect Methods 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 208000023513 hiccough Diseases 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000000366 juvenile effect Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000001595 mastoid Anatomy 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229910052895 riebeckite Inorganic materials 0.000 description 1
- 235000002020 sage Nutrition 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- MOCOXAJEZKHXSF-IHMBCTQLSA-M sodium;(2s,4as,6ar,6as,6br,8ar,10s,12as,14br)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1h-picene-2-carboxylate Chemical compound [Na+].C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C([O-])=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MOCOXAJEZKHXSF-IHMBCTQLSA-M 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000002747 voluntary effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
- A61K31/355—Tocopherols, e.g. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
- A61K31/51—Thiamines, e.g. vitamin B1
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
- A61K31/6615—Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7084—Compounds having two nucleosides or nucleotides, e.g. nicotinamide-adenine dinucleotide, flavine-adenine dinucleotide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/238—Saposhnikovia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/538—Schizonepeta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/41—Porphyrin- or corrin-ring-containing peptides
- A61K38/415—Cytochromes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0046—Ear
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention belongs to otopathy treatment and ear health care technology fields, and in particular to a kind of to treat otitis and the auristilla and its preparation method of ear function of feeling well with clear ear.The auristilla includes the naturally required agent of anti-inflammatory bacteriostatic agent, cell physiological function regulator, protective agent, agonist, promoting blood circulation and removing obstruction in channels dose, intelligence hardening agent, antioxidant and growth metabolism, and natural anti-inflammatory bacteriostatic agent is made of extracts such as Nantural non-toxic Chinese herbal medicine alcohol extract and honeysuckles;Cell physiological function regulator is made of vitamins and coenzyme substance;Protective agent includes trehalose, allantoin;Agonist includes ATP, cromoci;Promoting blood circulation and removing obstruction in channels dose including Notogineng Extract etc.;Cell normal growth metabolism must agent include amino acids, lactic acid class and inositol.The application is had one's ideas straightened out by tool antibacterial anti-inflammatory, clearing heat and detoxicating, promoting blood circulation and removing blood stasis, dispelling wind, is removed necrosis and promoted granulation, the various ingredients of anti-inflammatory anti-anaphylaxis, nutrition skin effect are made, and is had treatment otitis, ear itching, otalgia, tinnitus, maintenance ear brain and is made the pleasant multiple efficacies of ear brain.
Description
Technical field
The invention belongs to ENT diseases(Otopathy)Treatment and ear health care technology field, and in particular to a kind of to treat otitis
And the auristilla and preparation method thereof for ear function of feeling well with clear ear.
Background technology
Ear is one of the vitals of human body, according to tcm theory, the seven apertures that ears behaviour weight is wanted(Knowledge mouth and nose)
Two, and be directly connected with mouth and nose and brain.So ear diseases can not only injure ear organ itself, if cannot rationally or
Treatment in time, can also involve other organs, generate even more serious consequence.Ear is not only important hearing organ and ancients
One of the important channel of body and rehabilitation physical efficiency is improved, so, the quality of ear organ directly decides the health status of human body.
It is exactly otitis in addition to Hiccough and deaf in most common ear diseases.So-called otitis refers to just the inflammation that ear occurs,
It medically usually can exceptionally two kinds of otitis and tympanitis.Otitis externa refers to the inflammation of external auditory canal.Otitis externa can be divided into two classes, and one
Class is circumscribed external otitis, also known as furuncle of external auditory canal;The another kind of diffusivity inflammation for skin of external auditory canal, also known as diffusivity external ear
Road is scorching.Tympanitis is to involve middle ear(Including Eustachian tube, tympanum tympanic antrum and mastoid air cell etc.)The inflammatory disease of all or part of structure
Become, the overwhelming majority is nonspecific inflammation, can be divided into apyetous and suppurative two major classes.Apyetous includes secretory middle ear
Scorching, barotraumatic otitis media;Suppurative person is divided into acute and chronic.Due to environmental factor and self reason, people is added
Lack effectively ear's hygienic measures and consciousness, otitis externa and acute and chronic, otitis media suppurative have become ear-nose-throat department outpatient service
Common disease and frequently-occurring disease.Naval, air arm, coastal fisherman and swimming fan easily suffer from ear disease, are occupied especially with juvenile
More, adult is also very common.Though what serious disease is otitis be not, can often influence the work and life of patient, if be not treated in time or
Malpractice can also result in tinnitus or deafness or the tympanic membrane perforation and cause Hearing or forfeiture, or be infected brain etc.
Other tissues cause the outer complication of serious encephalic and jeopardize the life security of patient.
Since the diversity and complexity of the otitis cause of disease, such as external auditory canal water inlet and flu, pharyngitis, laryngitis can lead to ear
Inflammation, otitis are more than caused by simple aerobic bacteria or anaerobic infection, are likely to mixed infection or other in many cases
Reason, along with the complexity and its compactness contacted with the other vitals of body of ear organ structure, so otitis is not only
It is multiple, and be also difficult to treat.Currently, the method for reply otitis mainly has both at home and abroad:Doctor trained in Western medicine medication and TCM Therapy.Mesh
The preceding Western medicine for clinically being used to treat otitis includes mainly xacin-series antimicrobial, antibiotic and glucocorticoid medicine etc., agent
Type mainly has oral or injection and external preparation, and due to the extensive use of antibacterials, antibody-resistant bacterium increases, and causes chemistry anti-
The drug effect of bacterium drug is substantially reduced or fails, and has many antibiotic such as aminoglycoside antibiotics to also have different degrees of ear poison
Property, direct toxic effect is generated to inner ear, damages cochlea, hearing is influenced, some patients is caused drug-induced deafness or tinnitus occur;
A variety of serious toxic side effects of hormone medicine more allow people not go to select unless it is absolutely necessary certainly;And external Chinese medicament is more
It for scattered, cream, finish, is difficult to eliminate in addition to patient is also easy to produce earwax after, influences hearing, so that clinical application is restricted outer,
Also mostly containing to human body, there may be the Chinese medicines of toxic side effect or western medicine composition in its prescription;Oral or injection Chinese and Western medicine generates
The harmfulness of toxic side effect then bigger.Certainly, otitis especially tympanitis is tackled, also a kind of therapy is exactly to perform the operation to control
It treats, because otitis is mostly infectious diseases, in addition the uniqueness and complexity of ear structure, operative effect ideal may not be said, wind
Dangerous is also that general patient is unwilling to receive.Though said medicine or therapy have certain therapeutic effect to otitis patient, treat
Effect and safety it is ideal there is not been reported, even if some cure rates are higher, but because of its potential toxic side effect or harmfulness,
Otitis may be cured, but deaf or tinnitus, Hearing or produce other serious toxic side effects, and patient is allowed to obtain
Mistake is not repaid, is regretted to the very end of one's life.
In addition, according to the theory of motherland's medicine " sage preventive treatment of disease not treating the disease affected ", otitis is treated, the early ratio that prevents gets sick again
It goes to treat even more important.With advances in technology and the improvement of people's living standards, the health care consciousness of people is more and more stronger, various
The skin care item and health products of various kinds are also more and more, such as content in freckle cream, eye cream, lipstick, nose patch, but ear health care(With)Product are also rare
It reports and emerges, therefore, design, a kind of otitis that is directed to of exploitation has good prevention and treatment and has the refreshing ear function of clear ear
And be used conveniently and safely, to ear brain again the auristilla product with certain health care functions with highly important social value and
Application prospect.
Invention content
The application be designed to provide it is a kind of treat otitis and with clear ear feel well ear function auristilla and preparation method thereof,
The auristilla has significant therapeutic effect for otitis, there is antibacterial anti-inflammatory, clear ear to feel well ear, sterilizing and itch-relieving is promoting blood circulation and removing obstruction in channels, dispelling wind
The features such as having one's ideas straightened out, removing necrosis and promoting granulation, is nontoxic, is safe and efficient cannot be only used for otitis caused by many reasons, ear itching, otalgia
Etc. symptoms treatment and prevention, also significantly mitigate or alleviate tinnitus effect, meanwhile, also can be used as there is no ear suffer from children
And daily ear health treatment of the normal adult for the refreshing ear of clear ear, add its feature easy to use so that the product has
There is good society generalization application value.
Details are as follows for the technical solution that the application is taken.
A kind of to treat otitis and the auristilla for ear function of feeling well with clear ear, which includes natural anti-inflammatory bacteriostatic agent, cell life
Reason function regulator, cell-protecting, cellular agonist, promoting blood circulation and removing obstruction in channels dose, intelligence hardening agent, antioxidant and cell are normally given birth to
The long required agent of metabolism, under preferable case, which further includes preservative, further preferably in the case of, which further includes this hair
The acceptable safety barrier of bright preparation or auxiliary material;
The natural anti-inflammatory bacteriostatic agent, including but not limited to Nantural non-toxic Chinese herbal medicine alcohol extract, Honegsukle flower P.E, chrysanthemum extraction
One of which or several arbitrary proportion mixtures may be selected in object, Angelica Dahurica extract, menthol, peppermint oil;
The cell physiological function regulator makees the physiological function of the relevant soma of ear organ with important adjusting
With being made of vitamins and coenzyme substance;
One of which or the mixing of several arbitrary proportions may be selected in the cell-protecting, including but not limited to trehalose, allantoin
Object;
One of which or several arbitrary proportions may be selected in the cellular agonist, including but not limited to ATP disodiums, cromoci
Mixture;
Described promoting blood circulation and removing obstruction in channels dose, including but not limited to Notogineng Extract, notoginseng total saponin/glycosides, VB12, may be selected one of which or
Several arbitrary proportion mixtures;
One of which or several may be selected in the intelligence hardening agent, including but not limited to zinc gluconate, zinc lactate, zinc citrate
Kind arbitrary proportion mixture;
One of which or several arbitrary may be selected in the antioxidant, including but not limited to taurine, VC sodium, phytic acid, phytate
Scalemic thereof;
The required agent of cell normal growth metabolism, including but not limited to amino acids, lactic acid class, inositol, may be selected wherein one
Kind or the combination of several arbitrary proportions;
The preservative should be food grade preservative, including but not limited to potassium sorbate, dehydroactic acid sodium, potassium cinnamate, Radix Glycyrrhizae
One of which or several arbitrary proportion mixtures may be selected in acid, glycyrrhetate, propionate;
The acceptable safety barrier of the invention formulation or auxiliary material be prepare solvent needed for auristilla of the present invention and auxiliary agent or
Other auxiliary materials.
It is described it is a kind of treat otitis and with clear ear feel well ear function auristilla, the auristilla be liquor, total matter of effective ingredient
A concentration of 0.5-20.0% is measured, surplus is solvent;Each composition is in terms of mass fraction in effective ingredient, specially:
The natural anti-inflammatory bacteriostatic agent, is carried by Nantural non-toxic Chinese herbal medicine alcohol extract, Honegsukle flower P.E, chrysanthemum extract, the root of Dahurain angelica
Object, menthol and peppermint oil is taken to constitute, specifically:Nantural non-toxic Chinese herbal medicine alcohol extract 1.0-80.0, Honegsukle flower P.E
0.01-9.0, chrysanthemum extract 0.01-6.0, Angelica Dahurica extract 0.01-6.0, menthol 0.01-10.0, peppermint oil 0.01-
6.0;
The cell physiological function regulator, is made of, specifically vitamins and coenzyme class:
Vitamin V B1 0.01-6.0, vitamin V B2 0.001-1.0, niacinamide 0.01-10.0, VB5 0.01-6.0, VB6
0.01-6.0, niacin 0.01-5.0, Vc 0.01-5.0, Ve 0.001-1.0, biotin 0.001-1.0, Co-Q10
0.001-1.0, Coenzyme I 0.001-2.0, Coenzyme I I 0.001-2.0;
The cell-protecting, is made of trehalose and allantoin, specifically:Trehalose 0.01-9.0, allantoin 0.001-
2.0;
The cellular agonist is made of, specifically ATP disodiums and cromoci:ATP disodiums 0.01-5.0, cell color
Plain C 0.001-5.0;
It described promoting blood circulation and removing obstruction in channels dose, is made of Notogineng Extract, notoginseng total saponin/glycosides and VB12, specifically:Notogineng Extract
0.01-10.0, notoginseng total saponin/glycosides 0.001-2.0, VB12 0.01-10.0;
The intelligence hardening agent, be zinc gluconate, zinc lactate, zinc citrate, specifically:Zinc gluconate 0.01-4.0,
Zinc lactate 0.01-4.0, zinc citrate 0.01-4.0;
The antioxidant is taurine, VC sodium, phytic acid, phytate;Specifically:Taurine 0.01-5.0, VC sodium 0.01-
5.0, phytic acid 0.01-5.0, phytate 0.01-5.0;
The required agent of cell normal growth metabolism, is made of, specifically amino acids, lactic acid class and inositol:
Arginine 0.001-5.0, serine 0.001-5.0, glycine 0.001-9.0, glutamic acid 0.001-1.0, glutamine
0.01-8.0, lactic acid 0.01-5.0, sodium lactate 0.01-5.0, sodium glutamate 0.01-3.0;Inositol 0.01-6.0;
The preservative is made of potassium sorbate, dehydroactic acid sodium, potassium cinnamate, glycyrrhizic acid, glycyrrhetate and propionate, tool
For body:It is potassium sorbate 0.01-2.0, dehydroactic acid sodium 0.01-2.0, potassium cinnamate 0.01-2.0, glycyrrhizic acid 0.01-1.0, sweet
Oxalates 0.01-3.0, propionate 0.01-2.0;
The glycyrrhetate is one or two kinds of arbitrary proportion mixtures in potassium glycyrrhizana, sodium glycyrrhetate;
The propionate is one or two kinds of arbitrary proportion mixtures in sodium propionate, calcium propionate.
The solvent refers to or mixtures thereof purified water or 95% ethyl alcohol, and required raw material can be dissolved by being subject to.
The auristilla of the treatment otitis and ear function of feeling well with clear ear, in further optimization formula, effective ingredient it is total
Mass concentration is 1.0-18.0%, and surplus is water;Each composition is in terms of mass fraction in effective ingredient, specially:
The natural anti-inflammatory bacteriostatic agent, is carried by Nantural non-toxic Chinese herbal medicine alcohol extract, Honegsukle flower P.E, chrysanthemum extract, the root of Dahurain angelica
Object, menthol and peppermint oil is taken to constitute, specifically:Nantural non-toxic Chinese herbal medicine alcohol extract 2.0-76.0, Honegsukle flower P.E
0.01-8.0, chrysanthemum extract 0.01-5.0, Angelica Dahurica extract 0.01-5.0, menthol 0.01-8.0, peppermint oil 0.01-
5.0;
The cell physiological function regulator, is made of, specifically vitamins and coenzyme class:
Vitamin V B1 0.01-5.0, vitamin V B2 0.001-0.5, niacinamide 0.01-8.0, VB5 0.01-5.0, VB6
0.01-5.0, niacin 0.01-4.0, Vc 0.01-4.0, Ve 0.01-1.0;Biotin 0.001-0.60, Co-Q10 0.01-
1.0, Coenzyme I 0.01-1.20, Coenzyme I I 0.01-1.60;
The cell-protecting, is made of trehalose and allantoin, specifically:Trehalose 0.01-6.0, allantoin 0.01-
1.0;
The cellular agonist is made of, specifically ATP disodiums and cromoci:ATP disodiums 0.01-4.0, cell color
Plain C 0.01-4.0;
It described promoting blood circulation and removing obstruction in channels dose, is made of Notogineng Extract, notoginseng total saponin/glycosides and VB12, specifically:Notogineng Extract
0.01-8.0, notoginseng total saponin/glycosides 0.01-1.80, VB12 0.01-8.0;
The intelligence hardening agent, be zinc gluconate, zinc lactate, zinc citrate, specifically:Zinc gluconate 0.01-3.0,
Zinc lactate 0.01-3.0, zinc citrate 0.01-3.0;
The antioxidant is taurine, VC sodium, phytic acid, phytate;Specifically:Taurine 0.01-4.0, VC sodium 0.01-
4.0, phytic acid 0.01-4.0, phytate 0.01-4.0;
The required agent of cell normal growth metabolism, is made of, specifically amino acids, lactic acid class and inositol:Arginine
0.001-4.0, serine 0.001-3.0, glycine 0.001-6.0, glutamic acid 0.01-1.0, glutamine 0.01-5.0, breast
Sour 0.01-3.0, sodium lactate 0.01-4.0, sodium glutamate 0.01-2.0;Inositol 0.01-5.0;
The preservative is made of potassium sorbate, dehydroactic acid sodium, potassium cinnamate, glycyrrhizic acid, glycyrrhetate and propionate, tool
For body:Potassium sorbate 0.01-1.80, dehydroactic acid sodium 0.01-1.80, potassium cinnamate 0.01-1.80, glycyrrhizic acid 0.01-
0.80, glycyrrhetate 0.01-2.0, propionate 0.01-1.80.
The auristilla of the treatment otitis and ear function of feeling well with clear ear, in ear refreshing for tinnitus or clearly ear, cephalomenia
Auristilla is instilled by earhole in external auditory canal, massage effect is aided with after drop more preferably by side;In terms of dosage, 1-3 drops/time, 1-3 times/
Day;It is about 0.02-0.04mL per drop volume;When for tinnitus treatment, increase and decrease access times and dosage, tinnitus symptom can be taken the circumstances into consideration
Just when serious to drip, tinnitus is just dripped less when mitigating, but must not be dripped more;When the clear refreshing ear of ear is good for Er Shuer, it can take the circumstances into consideration to reduce make
With number and dosage, 1 time a day, 1-3 drops/time, it can uninterruptedly use for a long time.
The another object of the application, which also resides in provide, a kind for the treatment of otitis and the preparation for the ear function auristilla of feeling well with clear ear
Method.
The preparation method of the treatment otitis and ear function auristilla of feeling well with clear ear, specifically comprises the following steps:
(1)Effective ingredient in auristilla is divided into 4 groups according to material properties and the convenience of preparation and easy property processed, weighs match respectively
Dosage is spare in side, specifically:
First group, glycitols compound specifically has:Trehalose, inositol, zinc gluconate;
Second group, amino acids specifically have:Arginine, serine, glycine, glutamic acid, glutamine, glutamic acid
Sodium;
Third group, vitamin coenzymes class compound, specifically has:Vitamin V B1, vitamin V B2, niacinamide, VB5, VB6, niacin,
Vc、Ve;Biotin, Co-Q10, Coenzyme I, Coenzyme I I, VB12;
4th group, unclassified stores, specifically has in addition to the solvents:Allantoin, ATP disodiums, cromoci, notoginseng total saponin/glycosides, ox
Sulfonic acid, potassium sorbate, dehydroactic acid sodium, lactic acid, sodium lactate, zinc lactate, zinc citrate, VC sodium, phytic acid, phytate, cinnamic acid
Potassium, glycyrrhizic acid, glycyrrhetate, propionate, Nantural non-toxic Chinese herbal medicine alcohol extract, Honegsukle flower P.E, chrysanthemum extract, the root of Dahurain angelica carry
Take object, menthol and peppermint oil;
(2)By step(1)In second group of material weighing be placed in reaction kettle, the solvent of part formulation amount, stirring is then added
Mixing is dissolved, is stood, mixture A is obtained after filtering and impurity removing;
(3)By step(1)In the third group that weighs and the 4th group of material be placed in reaction kettle, the molten of part formulation amount is then added
Agent, stirring and dissolving mixing are stood, and mixture B is obtained after filtering and impurity removing;
(4)By step(3)Mixture B be slowly added into step(2)Mixture A in, after the completion of addition, be added step(1)
In first group of material component weighing, be eventually adding the solvent and auxiliary agent of remainder formula ratio, dissolving mixing, filtering and impurity removing,
PH=3.5 ~ 7.5 are adjusted, this is auristilla product provided herein.
Step(2), step(3), step(4)In carry out dissolving mixing operation when, operation temperature should not be greater than 45 DEG C, in order to avoid
The stability of drug effect is influenced, but is also not lower than 10 DEG C, in order to avoid influencing dissolving and mixed effect, preferably 24 DEG C or so are dissolved
Mixing operates.
Step(2), step(3), step(4)In carry out dissolving mixing operation when, it is preferred to use the homogeneous under vacuum condition
Emulsifying manner is operated, and can preferably ensure mixed effect.
Wherein, the Nantural non-toxic Chinese herbal medicine alcohol extract in the natural anti-inflammatory bacteriostatic agent contains the group of following mass fraction
Divide and is made by following processes:30~90 parts of honeysuckle, 40~80 parts of chrysanthemum, 40~75 parts of licorice, pueraria lobata 40~75
Part, 40~75 parts of Radix Salviae Miltiorrhizae, 20~55 parts of Radix Astragali, 30~60 parts of Radix Notoginseng, 10~50 parts of Radix Angelicae Sinensis, windproof 30~70 parts, schizonepeta 15~
70 parts, 20~80 parts of peppermint, 15~50 parts of the root of Dahurain angelica, 15~50 parts of akebi, 15~90 parts of Centipeda minima;Its process of preparing packet
It includes:The formula Chinese medicine is weighed, the particle that grain size is grain of rice size is crushed to, addition is equivalent to the dense of 5-20 times of quality of mixture
Degree is 10-90%(V/V)Ethyl alcohol, then multi-functional in including but not limited to vacuum or/and normal pressure or/and positive pressure environment
More than a few hours extracting solution is collected by filtration up to the alcohol extract in extraction under the conditions of set temperature is 20-105 DEG C in extractor.
The major design theory of the application is:The considerations of for safety first principle, raw material prescription of the present invention are same with traditional medicine food
Based on the Chinese herbal medicine that there is broad-spectrum antiseptic anti-inflammatory, clearing heat and detoxicating, promoting blood circulation and removing blood stasis, dispelling wind to have one's ideas straightened out in source, remove necrosis and promote granulation, it is aided with state
The tool of family's food or health food or food additives and nutrition fortifier or the above standard of National Pharmacopeia grade having no toxic side effect
There is anti-inflammatory anti-anaphylaxis and there is important conditioning and rehabilitative action, simultaneously to ear cranial nerve muscle cell and micro- blood circulation system
Also it with Nutritional Nursing Care ear brain and the biogenic substances for keeping ear brain pleasant and other effects be food-borne or drug induccd raw material or component, and uses
It is a kind of made of a kind of low-temperature environment-friendly technology method is refined can be with the preparation of target administration.According to modern medicine and traditional Chinese medicine
The theory of " being imitated in Transdermal absorption, external application " in, auristilla of the present invention not only have the function for the treatment of the ears diseases such as otitis, may be used also
Important conditioning and rehabilitative action are played to ear cranial nerve muscle cell and micro- blood circulation system.Simultaneously, it may have nutrition is protected
Reason ear brain and the effect for keeping ear brain pleasant.
Compared with traditional treatment otitis product or technical method, the advantages of the application, is mainly manifested in the following aspects:
(1)Compared with traditional treatment otitis drug, the auristilla without any to human body toxic side effect or harmful ingredient, it
Be it is a kind of there is broad-spectrum antiseptic anti-inflammatory, clearing heat and detoxicating, promoting blood circulation and removing blood stasis, dispelling wind to have one's ideas straightened out, remove necrosis and promote granulation, anti-inflammatory anti-anaphylaxis, nutrition skin
The targeting preparation having no toxic side effect;
(2)Product of the present invention is different from the oral or injectable Western medicine or form of Chinese drug of traditional treatment otitis, not liver
" first pass effect ", dosage is few, with obvious effects direct;In addition, its application method is simple and convenient, it is not only not necessarily to health care professional
Operation or guidance, can also use whenever and wherever possible;
(3)Auristilla of the present invention can not only be used for the therapeutic agent of otitis patient, but also as the ear health treatment of normal healthy people;
(4)The preparation method mild condition of auristilla of the present invention, simple for process, non-environmental-pollution.Due to the raw materials used in the present invention
It is more sensitive to physical and chemical factors such as high temperature and illumination for biogenic substances component, so, by process optimization, establishing one kind can
To prepare simple for process, non-environmental-pollution the technical method of auristilla of the present invention under room temperature or low temperature;Not only environmental protection but also section
Energy;
(5)The effect of product of the present invention existing drug, but having can be prolonged and repeated edible or the health food that uses and cosmetics
Safety.Though product of the present invention is externally applied product, its safety both can reach interior use(It is oral)Health food(Existing adjusting machine
The effect of body function will not also generate human body any acute, subacute or chronic hazard food)Standard, meanwhile, it also complies with
It can long-term external application《Cosmetics safety technical specification》Etc. national standards.
Specific implementation mode
Explanation is further explained to the application with reference to embodiment.
Embodiment 1
The present embodiment provides it is a kind of treat otitis and with clear ear feel well ear function auristilla, the auristilla be liquor, effectively at
The total mass concentration of part is 6%, and surplus is water, pH=5.0;Each composition is in terms of mass fraction in effective ingredient, specially:
The natural anti-inflammatory bacteriostatic agent, is carried by Nantural non-toxic Chinese herbal medicine alcohol extract, Honegsukle flower P.E, chrysanthemum extract, the root of Dahurain angelica
Object, menthol and peppermint oil is taken to constitute, specifically:Nantural non-toxic Chinese herbal medicine alcohol extract 40.0, Honegsukle flower P.E 5.0, chrysanthemum
Flower extract 3.0, Angelica Dahurica extract 3.0, menthol 5.0, peppermint oil 3.0;
The cell physiological function regulator, is made of, specifically vitamins and coenzyme class:
Vitamin V B1 5.0, vitamin V B2 0.5, niacinamide 8.0, VB5 4.0, VB6 3.0, niacin 4.0, Vc 1.0, Ve
0.4;Biotin 0.6, Co-Q10 0.6, Coenzyme I 0.8, Coenzyme I I 0.9;
The cell-protecting, is made of trehalose and allantoin, specifically:Trehalose 4.5, allantoin 0.9;
The cellular agonist is made of, specifically ATP disodiums and cromoci:ATP disodiums 4.0 and cromoci
4.0;
It described promoting blood circulation and removing obstruction in channels dose, is made of Notogineng Extract, notoginseng total saponin/glycosides and VB12, specifically:Notogineng Extract
4.0, notoginseng total saponin/glycosides 0.6, VB12 8.0;
The intelligence hardening agent, be zinc gluconate, zinc lactate, zinc citrate, specifically:Zinc gluconate 2.0, zinc lactate
3.0, zinc citrate 1.0;
The antioxidant is taurine, VC sodium, phytic acid, phytate;Specifically:Taurine 1.0, VC sodium 2.0, phytic acid
2.0, phytate 2.0;
The required agent of cell normal growth metabolism, is made of, specifically amino acids, lactic acid class and inositol:
Arginine 4.0, serine 1.0, glycine 8.0, glutamic acid 0.9, glutamine 7.0, lactic acid 4.0, sodium lactate 4.0, paddy
Propylhomoserin sodium 2.0, inositol 4.0;
The preservative is made of potassium sorbate, dehydroactic acid sodium, potassium cinnamate, glycyrrhizic acid, dipotassium glycyrrhizinate and sodium propionate, tool
For body:Potassium sorbate 1.0, dehydroactic acid sodium 0.8, potassium cinnamate 0.8, glycyrrhizic acid 0.5, dipotassium glycyrrhizinate 2.0, sodium propionate 0.9.
Wherein, the Nantural non-toxic Chinese herbal medicine alcohol extract in the natural anti-inflammatory bacteriostatic agent contains the group of following mass fraction
Divide and is made by following processes:60 parts of honeysuckle, 60 parts of chrysanthemum, 50 parts of licorice, 50 parts of pueraria lobata, 50 parts of Radix Salviae Miltiorrhizae, Radix Astragali
40 parts, 40 parts of Radix Notoginseng, 35 parts of Radix Angelicae Sinensis, windproof 40 parts, 40 parts of schizonepeta, 50 parts of peppermint, 35 parts of the root of Dahurain angelica, 30 parts of akebi, Centipeda minima
60 parts;Its process of preparing includes:The formula Chinese medicine is weighed, the particle that grain size is grain of rice size is crushed to, is added suitable
In a concentration of 10-90% of 5-20 times of quality of mixture(V/V)Ethyl alcohol, then in multi-functional extractor set temperature be 20-
A few hours are extracted under the conditions of 105 DEG C, extracting solution is collected by filtration up to the alcohol extract.
Specific when preparing, that steps are as follows is described for preparation method:
(1)Effective ingredient in auristilla is divided into 4 groups according to material properties and the convenience of preparation and easy property processed, weighs match respectively
Dosage is spare in side, specifically:
First group, glycitols compound specifically has:Trehalose, inositol, zinc gluconate;
Second group, amino acids specifically have:Arginine, serine, glycine, glutamic acid, glutamine, glutamic acid
Sodium;
Third group, vitamin coenzymes class compound, specifically has:Vitamin V B1, vitamin V B2, niacinamide, VB5, VB6, niacin,
Vc、Ve;Biotin, Co-Q10, Coenzyme I, Coenzyme I I, VB12;
4th group, unclassified stores, specifically has in addition to the solvents:Allantoin, ATP disodiums, cromoci, notoginseng total saponin/glycosides, ox
Sulfonic acid, potassium sorbate, dehydroactic acid sodium, lactic acid, sodium lactate, zinc lactate, zinc citrate, VC sodium, phytic acid, phytate, cinnamic acid
Potassium, glycyrrhizic acid, glycyrrhetate, propionate, Nantural non-toxic Chinese herbal medicine alcohol extract, Honegsukle flower P.E, chrysanthemum extract, the root of Dahurain angelica carry
Take object, menthol and peppermint oil;
(2)By step(1)In second group of material weighing be placed in reaction kettle, the solvent of part formulation amount, stirring is then added
Mixing is dissolved, is stood, mixture A is obtained after filtering and impurity removing;
(3)By step(1)In the third group that weighs and the 4th group of material be placed in reaction kettle, the molten of part formulation amount is then added
Agent, stirring and dissolving mixing are stood, and mixture B is obtained after filtering and impurity removing;
(4)By step(3)Mixture B be slowly added into step(2)Mixture A in, after the completion of addition, be added step(1)
In first group of material component weighing, be eventually adding the solvent and auxiliary agent of remainder formula ratio, dissolving mixing, filtering and impurity removing,
PH=5.0 are adjusted, this is auristilla product provided herein.
Step(2), step(3), step(4)In carry out dissolving mixing operation when, using the emulsifying under vacuum condition
Mode carries out dissolving mixing operation at 30 DEG C or so, preferably to ensure mixed effect.
To the skin irritation and pollutant of auristilla product prepared by the present embodiment(Heavy metal)Etc. safety indexes into
Detection is gone, as a result as shown in the following table 1, table 2(Every Testing index listed by table 1,2 is by can often eat(It uses)'s
The safe standard GB/T 16740-2014 of health food and《Cosmetics safety technical specification》(Version in 2015)New standard is held
Row).
1 skin irritation of table and pollutant(Heavy metal)Testing result
Index name | Testing result | Health food standarda | Cosmetic standardb | Remarks |
Multiple skin irritation | 0 degree | 2 degree or less | ||
Mercury (Hg), mg/kg | ≤ 0.18 | 0.3 | 1 | |
Arsenic (As), mg/kg | ≤ 0.6 | 1 | 2 | |
Lead(Pb), mg/kg | ≤ 1.5 | 2 | 10 | |
Cadmium(Cd), mg/kg | ≤ 1.8 | 5 | ||
Dioxane, mg/kg | ≤ 4.2 | 30 | ||
Methanol, mg/kg | ≤ 147 | 2000 | ||
Asbestos | It is not detected | It must not detect |
Note: aIt refer to GB 16740-2014 national food safety standard-health food safety standard; bIt refer to state food medicine
The new edition that product supervision and management general bureau promulgates《Cosmetics safety technical specification》(Version in 2015)(2015 No. 268).
2 microbiological indicator of table
Project | Index | Health food standarda | Cosmetic standardb |
Total plate count, CFU/g or CFU/mL≤ | 89 | 1000 | 1000 |
Heat-resisting coliform MPN/g, or/mL | Nothing | 0.43 | Nothing |
Staphylococcus aureus/g, or/mL | 0/25g | 0/25g | 0/25g |
Pseudomonas aeruginosa/g, or/mL | 0/25g | 0/25g | 0/25g |
Salmonella/g, or/mL | 0/25g | 0/25g | 0/25g |
Yeast and mold, CFU/g or CFU/mL≤ | 11 | 50 | 50 |
The detection knot of the safety indexes such as pollutants and microorganism such as heavy metal of auristilla of the present invention it can be seen from table 1 and 2
Fruit not only complies fully with the safe standard GB/T 16740-2014 of the health food that can often eat, and also being compliant with can be long-term
What is used is newest《Cosmetics safety technical specification》(Version in 2015)Standard.
By taking auristilla product prepared by the present embodiment as an example, inventor has carried out part actual human body application experiment(It is voluntary
Person), detailed process is briefly discussed below.
The practical application effect of otitis patient
220 other normal 7-63 Sui otitis patients of age of sign are selected, are randomly divided into 2 groups:A groups control group and the experiment of B groups
Group, every group 110, A groups Ofloxacin class auristilla, B groups auristilla of the present invention.Usage:Cephalomenia side, by auristilla
Liquid outlet is directed at duct, instills in ear, and a moment is massaged after drop.Dosage:1-6 drops/time, 1-3 times/day, the course for the treatment of is generally 7-14 days,
It can take the circumstances into consideration increase and decrease access times and dosage according to the state of an illness.Efficacy assessment standard:With reference to country《Antibacterials clinical research guidance is former
Then》It formulates as follows:Recovery from illness:Otitis inflammatory resolution, other sign symptoms are normal;It is effective:The state of an illness is clearly better but does not restore completely
Normally;Effectively:The state of an illness is improved after medication, but not apparent enough;In vain:The state of an illness adds severe one without obviously improving or having after medication.
As a result it is:A groups total effective rate 87.8%(P<0.01), the total effective rate 96.5% of B groups(P<0.01), illustrate auristilla of the present invention
Curative effect is better than Common Antibiotics Ofloxacin class, achieves ideal effect.
The application effect of Normal volunteers
The random non-otitis health men and women volunteer for selecting 196 ages 18-70 Sui tries out product of the present invention, checks trier's
With rear feeling.Usage:The liquid outlet of auristilla is directed at duct by cephalomenia side, is instilled one and is picked up the ears interior, massage a moment after drop, separately
It does not drip as control side.Dosage:1-3 drops/time, 1-3 times/day, increase and decrease access times and dosage can be taken the circumstances into consideration according to personal like.
Effective evaluation is carried out after 2 months on probation.Effective evaluation index or standard:With reference to country《Antibacterials guideline of clinical investigations》
Feel to be divided into following 4 kinds of situations after formulating the use of trier: A:Feel pleasant penetrating, the other side is also intended to seek drop;B:Feel compared with
It is good;C:Feel general or insentience;D:Feel to feel bad.As a result it is:A 163(83.2%), B 24(12.2%), C 9
(4.6%), D 0(0.0%), feel that pleasant penetrating person accounts for 83.2%, in addition feeling preferable person 12.2%, the pleasant rate of panesthesia is
95.4%(P<0.01), achieve ideal effect.
Overall application effect shows:For newly sending out otitis patient serious, apparent mitigation can have been experienced after instilling for the first time
With mitigation;And be directed to healthy population, instill one pick up the ears it is interior after, which can allow the healthy human ear being dropped into be felt more
Penetrating, more pleasant, most volunteers can also ask to drip another ear again.
For above-mentioned experiment, just it is described below using the briefly citing of the part model case situation of process:
Lee:Female, 63 years old, certain government functionary was retired, suffers from tympanitis for many years, controls be not cured long, dripped ear using product of the present invention,
Dosage:2-5 drops/time, 2-3 times/day or each drop 1 time daily morning and evening.It uses ear sense pleasant for the first time, is had using 1 week symptom apparent
Mitigate, was almost recovered using 6 weeks or so.
Mr. Wang, male, 55 years old, certain college professor, aggravation before otitis tinnitus more than 10 years, 4 years, a variety of medical procedures of seeking help
It has no result, drips ear, dosage using product of the present invention:2-10 drops/time, it 1-6 times/day, was taken an evident turn for the better using 2 weeks or so.Extremely
The present uses auristilla of the present invention more than 3 years, and not only tinnitus symptom is substantially reduced, and otitis also has no other adverse reactions.
Zhao, female, 50 years old, certain college professor, the otitis that arrives because of pharyngitis happened suddenly serious tinnitus 1 day in turn, ear intracerebral diseases caused by external factors
Feel hurricane your writing and influence thinking ability, drips ear, dosage using product of the present invention:2-10 drops/time, it 1-6 times/day, uses for the first time
Symptom has substantially reduced, is almost recovered using 2 weeks or so.
Zhang:Female, 64 years old, certain government functionary was retired, health, dripped ear, dosage using product side of the present invention:
1-3 drops/time, 1-3 times/day or each drop 1 time daily morning and evening.Using for the first time i.e. have pleasant penetrating more invigorative feeling, the other side
Also it is intended to instill.Or so April is used continuously, other than pleasant penetrating more invigorative feeling, has no other adverse reactions.
Liu:Man, 32 years old, certain company manager, health dripped ear, dosage using product side of the present invention:1-3 drops/
It is secondary, 1-3 times/day or each drop 1 time daily morning and evening.Using for the first time i.e. there is pleasant penetrating more invigorative feeling, the other side to be also intended to drip
Enter.Continuous use 2 months or so, other than pleasant penetrating more invigorative feeling, has no other adverse reactions.
Hu:Female, 21 years old, certain company clerk, health dripped ear, dosage using product side of the present invention:1-3 drops/
It is secondary, 1-3 times/day.Using having pleasant penetrating more invigorative feeling for the first time, the other side also wants to instill.It is left that June is used continuously
The right side has no other adverse reactions other than pleasant penetrating more invigorative feeling.
Embodiment 2
The auristilla product for the treatment of otitis and ear function of feeling well with clear ear that the present embodiment is provided, preparation method is substantially the same as real
Example 1 is applied, only adjustment member formula is as follows:
The auristilla is liquor, and the total mass concentration of effective ingredient is 0.5%, and surplus is water, pH=3.5;In effective ingredient respectively at
Part is in terms of mass fraction, specially:
The natural anti-inflammatory bacteriostatic agent, is carried by Nantural non-toxic Chinese herbal medicine alcohol extract, Honegsukle flower P.E, chrysanthemum extract, the root of Dahurain angelica
Object, menthol and peppermint oil is taken to constitute, specifically:Nantural non-toxic Chinese herbal medicine alcohol extract 80.0, Honegsukle flower P.E 0.01,
Chrysanthemum extract 0.01, Angelica Dahurica extract 0.01, menthol 0.01, peppermint oil 0.01;
The cell physiological function regulator, is made of, specifically vitamins and coenzyme class:
Vitamin V B1 0.01, VB2 0.001, niacinamide 0.01, VB5 0.01, VB6 0.01, niacin 0.01, Vc 0.01, Ve
0.001;Biotin 1.0, Co-Q10 0.001, Coenzyme I 2.0, Coenzyme I I 2.0;
The cell-protecting, is made of trehalose, specifically:Trehalose 0.01;
The cellular agonist is made of, specifically ATP disodiums:ATP disodiums 5.0;
It described promoting blood circulation and removing obstruction in channels dose, is made of notoginseng total saponin/glycosides, specifically:Notoginseng total saponin/glycosides 2.0;
The intelligence hardening agent, be zinc gluconate, zinc lactate, zinc citrate, specifically:Zinc gluconate 4.0, zinc lactate
4.0, zinc citrate 4.0;
The antioxidant is taurine, VC sodium, phytic acid, phytate;Specifically:Taurine 5.0, VC sodium 5.0, phytic acid
5.0, phytate 5.0;
The required agent of cell normal growth metabolism, is made of, specifically amino acids:It is arginine 5.0, serine 5.0, sweet
Propylhomoserin 9.0, glutamic acid 1.0;
The preservative, is made of potassium sorbate and dehydroactic acid sodium, specifically:Potassium sorbate 2.0, dehydroactic acid sodium
0.01。
Wherein, the Nantural non-toxic Chinese herbal medicine alcohol extract in the natural anti-inflammatory bacteriostatic agent contains the group of following mass fraction
Divide and is made by following processes:90 parts of honeysuckle, 80 parts of chrysanthemum, 75 parts of licorice, 75 parts of pueraria lobata, 75 parts of Radix Salviae Miltiorrhizae, Radix Astragali
255 parts, 60 parts of Radix Notoginseng, 50 parts of Radix Angelicae Sinensis, windproof 30 parts, 15 parts of schizonepeta, 20 parts of peppermint, 15 parts of the root of Dahurain angelica, 15 parts of akebi, Centipeda minima
15 parts;Its process of preparing includes:The formula Chinese medicine is weighed, the particle that grain size is grain of rice size is crushed to, is added suitable
In a concentration of 10-90% of 5-20 times of quality of mixture(V/V)Ethyl alcohol, then in multi-functional extractor set temperature be 20-
A few hours are extracted under the conditions of 105 DEG C, extracting solution is collected by filtration up to the alcohol extract.
Embodiment 3
The auristilla product for the treatment of otitis and ear function of feeling well with clear ear that the present embodiment is provided, preparation method is substantially the same as real
Example 1 is applied, only adjustment member formula is as follows:
The auristilla is liquor, and the total mass concentration of effective ingredient is 20.0%, and surplus is water, pH=7.5;In effective ingredient respectively at
Part is in terms of mass fraction, specially:
The natural anti-inflammatory bacteriostatic agent, is carried by Nantural non-toxic Chinese herbal medicine alcohol extract, Honegsukle flower P.E, chrysanthemum extract, the root of Dahurain angelica
Object, menthol and peppermint oil is taken to constitute, specifically:Nantural non-toxic Chinese herbal medicine alcohol extract 1.0, Honegsukle flower P.E 9.0, chrysanthemum
Flower extract 6.0, Angelica Dahurica extract 6.0, menthol 10.0, peppermint oil 6.0;
The cell physiological function regulator, is made of, specifically vitamins and coenzyme class:
Vitamin V B1 6.0, VB2 1.0, niacinamide 10.0, VB5 6.0, VB6 6.0, niacin 5.0, Vc 5.0, Ve 1.0;
Biotin 0.001, Co-Q10 1.0, Coenzyme I 0.001, Coenzyme I I 0.001;
The cell-protecting, is made of trehalose and allantoin, specifically:Trehalose 9.0, allantoin 0.001;
The cellular agonist is made of, specifically ATP disodiums and cromoci:ATP disodiums 0.01 and cromoci
5.0;
It described promoting blood circulation and removing obstruction in channels dose, is made of Notogineng Extract, notoginseng total saponin/glycosides and VB12, specifically:Notogineng Extract
10.0, notoginseng total saponin/glycosides 0.001, VB12 10.0;
The intelligence hardening agent, be zinc gluconate, zinc lactate, zinc citrate, specifically:Zinc gluconate 0.01, lactic acid
Zinc 0.01, zinc citrate 0.01;
The antioxidant is taurine, VC sodium, phytic acid, phytate;Specifically:Taurine 0.01, VC sodium 0.01, phytic acid
0.01, phytate 0.01;
The required agent of cell normal growth metabolism, is made of, specifically amino acids, lactic acid and inositol:
Arginine 0.001, serine 0.001, glycine 0.001, glutamic acid 0.001, glutamine 0.01, lactic acid 0.01, paddy
Propylhomoserin sodium 0.01, inositol 0.01;
The preservative is made of potassium sorbate, dehydroactic acid sodium, potassium cinnamate, glycyrrhizic acid, Carbenoxolone Sodium and sodium propionate, tool
For body:Potassium sorbate 0.01, dehydroactic acid sodium 2.0, potassium cinnamate 0.01, glycyrrhizic acid 0.05, Carbenoxolone Sodium 0.01, sodium propionate
0.01。
Wherein, the Nantural non-toxic Chinese herbal medicine alcohol extract in the natural anti-inflammatory bacteriostatic agent contains the group of following mass fraction
Divide and is made by following processes:30 parts of honeysuckle, 40 parts of chrysanthemum, 40 parts of licorice, 40 parts of pueraria lobata, 40 parts of Radix Salviae Miltiorrhizae, Radix Astragali
20 parts, 30 parts of Radix Notoginseng, 10 parts of Radix Angelicae Sinensis, windproof 70 parts, 70 parts of schizonepeta, 80 parts of peppermint, 50 parts of the root of Dahurain angelica, 50 parts of akebi, Centipeda minima
90 parts;Its process of preparing includes:The formula Chinese medicine is weighed, the particle that grain size is grain of rice size is crushed to, is added suitable
In a concentration of 10-90% of 5-20 times of quality of mixture(V/V)Ethyl alcohol, then in multi-functional extractor set temperature be 20-
A few hours are extracted under the conditions of 105 DEG C, extracting solution is collected by filtration up to the alcohol extract.
Embodiment 4
The auristilla product for the treatment of otitis and ear function of feeling well with clear ear that the present embodiment is provided, preparation method is substantially the same as real
Example 1 is applied, only adjustment member formula is as follows:
The auristilla is liquor, and the total mass concentration of effective ingredient is 3%, and surplus is water, pH=4.0;Each composition in effective ingredient
In terms of mass fraction, specially:
The natural anti-inflammatory bacteriostatic agent, is carried by Nantural non-toxic Chinese herbal medicine alcohol extract, Honegsukle flower P.E, chrysanthemum extract, the root of Dahurain angelica
Object, menthol and peppermint oil is taken to constitute, specifically:Nantural non-toxic Chinese herbal medicine alcohol extract 10.0, Honegsukle flower P.E 1.0, chrysanthemum
Flower extract 1.0, Angelica Dahurica extract 1.0, menthol 1.0, peppermint oil 1.0;
The cell physiological function regulator, is made of, specifically vitamins and coenzyme class:
Vitamin V B1 3.0, VB2 0.5, niacinamide 5.0, VB5 3.0, VB6 3.0, niacin 3.0, Vc 3.0, Ve 0.5;
Biotin 0.5, Co-Q10 0.5, Coenzyme I 1.0, Coenzyme I I 1.0;
The cell-protecting, is made of trehalose and allantoin, specifically:Trehalose 4.0, allantoin 1.0;
The cellular agonist is made of, specifically ATP disodiums and cromoci:ATP disodiums 3.0 and cromoci
2.0;
It described promoting blood circulation and removing obstruction in channels dose, is made of notoginseng total saponin/glycosides and VB12, specifically:Notoginseng total saponin/glycosides 1.0, VB12
5.0;
The intelligence hardening agent is zinc gluconate, specifically:Zinc gluconate 2.0;
The antioxidant is taurine;Specifically:Taurine 3.0;
The required agent of cell normal growth metabolism, is made of, specifically amino acids, sodium lactate and inositol:Arginine
3.0, serine 3.0, glycine 5.0, glutamic acid 0.5, glutamine 4.0, sodium lactate 3.0, sodium glutamate 2.0, inositol 3.0;
The preservative is made of potassium sorbate, dehydroactic acid sodium, potassium cinnamate, glycyrrhizic acid, Carbenoxolone Sodium and calcium propionate, tool
For body:Potassium sorbate 1.0, dehydroactic acid sodium 1.0, potassium cinnamate 1.0, glycyrrhizic acid 0.5, Carbenoxolone Sodium 2.0, calcium propionate 1.0.
Embodiment 5
The auristilla product for the treatment of otitis and ear function of feeling well with clear ear that the present embodiment is provided, preparation method is substantially the same as real
Example 1 is applied, only adjustment member formula is as follows:
The auristilla is liquor, and the total mass concentration of effective ingredient is 9%, and surplus is water, pH=5.5;Each composition in effective ingredient
In terms of mass fraction, specially:
The natural anti-inflammatory bacteriostatic agent, is carried by Nantural non-toxic Chinese herbal medicine alcohol extract, Honegsukle flower P.E, chrysanthemum extract, the root of Dahurain angelica
Object, menthol and peppermint oil is taken to constitute, specifically:Nantural non-toxic Chinese herbal medicine alcohol extract 30.0, Honegsukle flower P.E 3.0, chrysanthemum
Flower extract 2.0, Angelica Dahurica extract 2.0, menthol 3.0, peppermint oil 2.0;
The cell physiological function regulator, is made of, specifically vitamins and coenzyme class:
Vitamin V B1 1.0, VB2 0.1, niacinamide 1.0, VB5 1.0, VB6 1.0, niacin 1.0, Vc 0.5, Ve 0.05;
Biotin 0.01, Co-Q10 0.5;
The cell-protecting, is made of trehalose and allantoin, specifically:Trehalose 3.0, allantoin 0.01;
The cellular agonist is made of, specifically ATP disodiums and cromoci:ATP disodiums 0.5 and cromoci
0.05;
It described promoting blood circulation and removing obstruction in channels dose, is made of Notogineng Extract, notoginseng total saponin/glycosides and VB12, specifically:Notogineng Extract
4.0, notoginseng total saponin/glycosides 0.01, VB12 2.0;
The intelligence hardening agent is zinc gluconate, specifically:Zinc gluconate 0.05;
The antioxidant is taurine;Specifically:Taurine 1.0;
The required agent of cell normal growth metabolism, is made of, specifically amino acids, lactic acid class and inositol:
Arginine 1.0, serine 1.0, glycine 2.0, glutamic acid 0.01, glutamine 1.0, lactic acid 1.0, sodium lactate 1.0, paddy
Propylhomoserin sodium 1.0, inositol 1.0;
The preservative is made of potassium sorbate, dehydroactic acid sodium, potassium cinnamate, glycyrrhizic acid, Carbenoxolone Sodium and sodium propionate, tool
For body:Potassium sorbate 0.05, dehydroactic acid sodium 0.2, potassium cinnamate 0.05, glycyrrhizic acid 0.5, Carbenoxolone Sodium 0.05, sodium propionate
0.05;
Embodiment 6
The auristilla product for the treatment of otitis and ear function of feeling well with clear ear that the present embodiment is provided, preparation method is substantially the same as real
Example 1 is applied, only adjustment member formula is as follows:
The auristilla is liquor, and the total mass concentration of effective ingredient is 12%, and surplus is water, adjusts pH=6.0;It is each in effective ingredient
Composition is in terms of mass fraction, specially:
The natural anti-inflammatory bacteriostatic agent, is made of, specifically Honegsukle flower P.E, chrysanthemum extract oil:Honegsukle flower P.E
4.0, chrysanthemum extract 5.0;
The cell physiological function regulator, is made of, specifically vitamins and coenzyme class:
Vitamin V B1 2.0, VB2 0.03, niacinamide 4.0, VB5 2.0, VB6 2.0, niacin 2.0;
Biotin 0.05, Co-Q10 0.5;
The cell-protecting, is made of trehalose and allantoin, specifically:Trehalose 4.0, allantoin 0.05;
The cellular agonist is made of, specifically ATP disodiums and cromoci:ATP disodiums 2.0 and cromoci
0.5;
It described promoting blood circulation and removing obstruction in channels dose, is made of Notogineng Extract, notoginseng total saponin/glycosides and VB12, specifically:Notogineng Extract
8.0, notoginseng total saponin/glycosides 0.08, VB12 4.0;
The intelligence hardening agent is zinc gluconate, specifically:Zinc gluconate 0.8;
The antioxidant is taurine;Specifically:Taurine 2.0;
The required agent of cell normal growth metabolism, is made of, specifically amino acids, lactic acid class and inositol:
Arginase 12 .0, serine 2.0, glycine 4.0, glutamic acid 0.1, glutamine 5.0, lactic acid 2.0, sodium lactate 2.0, paddy
Propylhomoserin sodium 2.0, inositol 2.0;
The preservative is made of, specifically potassium sorbate, dehydroactic acid sodium and potassium cinnamate:Potassium sorbate 0.1, dehydrogenation
Sodium acetate 0.2, potassium cinnamate 0.1;
Embodiment 7
The auristilla product for the treatment of otitis and ear function of feeling well with clear ear that the present embodiment is provided, preparation method is substantially the same as real
Example 1 is applied, only adjustment member formula is as follows:
The auristilla is liquor, and the total mass concentration of effective ingredient is 16%, and surplus is water, adjusts pH=5.5;It is each in effective ingredient
Composition is in terms of mass fraction, specially:
The natural anti-inflammatory bacteriostatic agent, is made of, specifically Nantural non-toxic Chinese herbal medicine alcohol extract:Nantural non-toxic Chinese herbal medicine alcohol extracting
Liquid 40.0;
The cell physiological function regulator, is made of, specifically vitamins and coenzyme class:
Vitamin V B1 4.0, VB2 0.03, niacinamide 8.0, VB5 4.0, VB6 4.0, niacin 4.0;Biotin 0.06;
The cell-protecting, is made of allantoin, specifically:Allantoin 1.5;
The cellular agonist, is made of cromoci, specifically:Cromoci 4.0;
It described promoting blood circulation and removing obstruction in channels dose, is made of VB12, specifically:VB12 8.0;
The intelligence hardening agent is zinc gluconate, specifically:Zinc gluconate 3.0;
The antioxidant is taurine;Specifically:Taurine 4.0;
The required agent of cell normal growth metabolism, is made of, specifically inositol:Inositol 4.0;
The preservative, is made of potassium sorbate, specifically:Potassium sorbate 1.5.
The test evaluation method of reference implementation example 1 selects 140 ages 20-65 Sui at random, the course of disease -10 years 2 days is made a definite diagnosis
The volunteer that differs of otitis severity, 7 groups, every group of 20 volunteers, respectively prepared by Application Example 1 ~ 7 are set
Auristilla product carries out drop ear experiment.
Usage:The liquid outlet of auristilla is directed at duct, instilled in ear, a moment is massaged after drop by cephalomenia side;Dosage:1-3
Drop/time, 1-3 times/day.Efficacy evaluation is carried out after 2 months on probation.
Statistical result shows that auristilla effect prepared by embodiment 1 is best, total effective rate 100.0%(P<0.05);It is real
The auristilla effect for applying the preparation of example 2 is worst, total effective rate 60.0%(P<0.05);It is other to be followed successively by:
The total effective rate of embodiment 3 is 95.0%(P<0.05);The total effective rate of embodiment 4 is 90.0%(P<0.05);
The total effective rate of embodiment 5 is 85.0%(P<0.05);The total effective rate of embodiment 6 is 75.0%(P<0.05);
The total effective rate of embodiment 7 is 65.0%(P<0.05).
Embodiment 8
The auristilla product for the treatment of otitis and ear function of feeling well with clear ear that the present embodiment is provided, preparation method is substantially the same as real
Example 1 is applied, only adjustment member formula is as follows:
The auristilla is liquor, and the total mass concentration of effective ingredient is 8%, and surplus is water, adjusts pH=5.0;It is each in effective ingredient
Composition is in terms of mass fraction, specially:
The natural anti-inflammatory bacteriostatic agent, is carried by Nantural non-toxic Chinese herbal medicine alcohol extract, Honegsukle flower P.E, chrysanthemum extract, the root of Dahurain angelica
Object, menthol and peppermint oil is taken to constitute, specifically:Nantural non-toxic Chinese herbal medicine alcohol extract 40.0, Honegsukle flower P.E 5.0, chrysanthemum
Flower extract 3.0, Angelica Dahurica extract 3.0, menthol 5.0, peppermint oil 3.0;
The cell physiological function regulator, is made of, specifically vitamins and coenzyme class:
Vitamin V B1 0.2, VB2 0.8, niacinamide 0.01, VB5 0.01, VB6 0.01, niacin 0.01, Vc 0.01, Ve
0.001;
Biotin 1.0, Co-Q10 0.001, Coenzyme I 2.0, Coenzyme I I 2.0;
The cell-protecting, is made of trehalose and allantoin, specifically:Trehalose 0.01, allantoin 2.0;
The cellular agonist is made of, specifically ATP disodiums and cromoci:ATP disodiums 5.0 and cromoci
0.001;
It described promoting blood circulation and removing obstruction in channels dose, is made of Notogineng Extract, notoginseng total saponin/glycosides and VB12, specifically:Notogineng Extract
4.0, notoginseng total saponin/glycosides 2.0, VB12 0.01;
The intelligence hardening agent is zinc gluconate, specifically:Zinc gluconate 4.0;
The antioxidant is taurine;Specifically:Taurine 5.0;
The required agent of cell normal growth metabolism, is made of, specifically amino acids and inositol:Arginine 5.0, serine
5.0, glycine 9.0, glutamic acid 1.0, inositol 6.0;
The preservative, is made of potassium sorbate and dehydroactic acid sodium, specifically:Potassium sorbate 2.0, dehydroactic acid sodium
0.01。
Embodiment 9
The auristilla product for the treatment of otitis and ear function of feeling well with clear ear that the present embodiment is provided, preparation method is substantially the same as real
Example 1 is applied, only adjustment member formula is as follows:
The auristilla is liquor, and the total mass concentration of effective ingredient is 8%, and surplus is water, adjusts pH=5.0;It is each in effective ingredient
Composition is in terms of mass fraction, specially:
The natural anti-inflammatory bacteriostatic agent, is carried by Nantural non-toxic Chinese herbal medicine alcohol extract, Honegsukle flower P.E, chrysanthemum extract, the root of Dahurain angelica
Object, menthol and peppermint oil is taken to constitute, specifically:Nantural non-toxic Chinese herbal medicine alcohol extract 70.0, Honegsukle flower P.E 7.0, chrysanthemum
Flower extract 4.0, Angelica Dahurica extract 4.0, menthol 4.0, peppermint oil 4.0;
The cell physiological function regulator, is made of, specifically vitamins and coenzyme class:
Vitamin V B1 6.0, VB2 1.0, niacinamide 10.0, VB5 6.0, VB6 6.0, niacin 5.0, Vc 5.0, Ve 1.0;
Biotin 0.001, Co-Q10 1.0, Coenzyme I 0.001, Coenzyme I I 0.001;
The cell-protecting, is made of trehalose and allantoin, specifically:Trehalose 9.0, allantoin 0.001;
The cellular agonist is made of, specifically ATP disodiums and cromoci:ATP disodiums 0.01 and cromoci
5.0;
It described promoting blood circulation and removing obstruction in channels dose, is made of Notogineng Extract, notoginseng total saponin/glycosides and VB12, specifically:Notogineng Extract
1.0, notoginseng total saponin/glycosides 0.001, VB12 10.0;
The intelligence hardening agent is zinc gluconate, specifically:Zinc gluconate 0.01;
The antioxidant is taurine;Specifically:Taurine 0.01;
The required agent of cell normal growth metabolism, is made of, specifically amino acids and inositol:
Arginine 0.001, serine 0.001, glycine 0.001, glutamic acid 0.001, inositol 0.01;
The preservative, is made of potassium sorbate and dehydroactic acid sodium, specifically:Potassium sorbate 0.01, dehydroactic acid sodium
2.0。
The test evaluation method of reference implementation example 1 selects -12 years 1 week 80 ages 20-66 Sui, the course of disease ears made a definite diagnosis at random
2 groups are arranged in the volunteer that scorching severity differs, and every group of 40 volunteers, Application Example 8, embodiment 9 are made respectively
Standby different ratio but the auristilla product of identical mass percentage concentration carry out drop ear experiment.
Usage:The liquid outlet of auristilla is directed at duct, instilled in ear, a moment is massaged after drop by cephalomenia side;Dosage:1-3
Drop/time, 1-3 times/day.Efficacy evaluation is carried out after 2 months on probation.
Statistical result shows that auristilla effect prepared by embodiment 9 is best, total effective rate 95.0%(P<0.05), implement
Auristilla effect prepared by example 8 is weaker than embodiment 9, total effective rate 82.5%(P<0.05).
Based on the above embodiments and the statistics of prolonged application effect shows that the present invention has following advantageous effect more outstanding:
(1)Clearing heat and detoxicating with antibacterial anti-inflammatory, clear ear is felt well ear, and sterilizing and itch-relieving is promoting blood circulation and removing obstruction in channels, and dispelling wind is had one's ideas straightened out, and removes necrosis and promote granulation, and is resisted
Scorching anti-anaphylaxis and other effects.This product is different from conventional medicament, and typical feature is:Has a broad antifungal spectrum, it is with obvious effects;There is disease that can disappear, it is ill-mannered
It can prevent;Automatically it oozes, it is easy to use;It is nontoxic, it is safe and efficient.
(2)The treatment and prevention of the symptoms such as otitis caused by many reasons, ear itching, otalgia are not only can be widely used for, also
The apparent effect mitigated or alleviate tinnitus symptom.
(3)It is safe, it is widely applicable.Auristilla of the present invention has no toxic side effect, is non-stimulated, without allergy, is suitable for almost
All groups.And it is quick, and can be used for a long time.
(4)Auristilla of the present invention not only has the function for the treatment of the ears disease such as otitis, be alternatively arranged as the children that there is no ear to suffer from and
Daily ear health treatment of the normal adult for the refreshing ear of clear ear, with significant Nutritional Nursing Care ear brain and the work(for keeping ear pleasant
Effect.In implementation " Health China strategy " process of construction, auristilla of the present invention will be made important for the maintenance of the ear brain health of people
Contribution.
(5)Auristilla of the present invention may determine that the health status of ear;It is dropped in healthy duct, is not had abnormal sense
Feel, penetrating comfort sense of only clearly soothing the spirit;If dropping in otitis tinnitus patient ear, there are treatment and mitigation, after instillation
The feeling that sensible, inflammation of releiving mitigates is had, otitis tinnitus is more serious, and sensible sense of releiving is more apparent.
Claims (10)
1. a kind for the treatment of otitis and the auristilla for ear function of feeling well with clear ear, it is characterised in that:The auristilla includes natural anti-inflammatory
Bacteriostatic agent, cell physiological function regulator, cell-protecting, cellular agonist, promoting blood circulation and removing obstruction in channels dose, it is intelligence hardening agent, anti-oxidant
Agent, the required agent of cell normal growth metabolism;
The natural anti-inflammatory bacteriostatic agent, including but not limited to Nantural non-toxic Chinese herbal medicine alcohol extract, Honegsukle flower P.E, chrysanthemum extraction
Object, Angelica Dahurica extract, menthol, peppermint oil select one of which or several arbitrary proportion mixtures;
The cell physiological function regulator makees the physiological function of the relevant soma of ear organ with important adjusting
With being made of vitamins and coenzyme substance;
The cell-protecting, including but not limited to trehalose, allantoin select one of which or the mixing of several arbitrary proportions
Object;
The cellular agonist, including but not limited to ATP disodiums, cromoci select one of which or several arbitrary proportions mixed
Close object;
Described promoting blood circulation and removing obstruction in channels dose, including but not limited to Notogineng Extract, notoginseng total saponin/glycosides, VB12 select one of which or several
Kind arbitrary proportion mixture;
The intelligence hardening agent, including but not limited to zinc gluconate, zinc lactate, zinc citrate select one of which or several
Arbitrary proportion mixture;
The antioxidant, including but not limited to taurine, VC sodium, phytic acid, phytate select one of which or several arbitrary ratios
Example mixture;
The required agent of cell normal growth metabolism, including but not limited to amino acids, lactic acid class, inositol, select one of which
Or several arbitrary proportion combinations.
2. the auristilla for the treatment of otitis and ear function of feeling well with clear ear as described in claim 1, which is characterized in that the auristilla packet
Include preservative;The preservative, including but not limited to potassium sorbate, dehydroactic acid sodium, potassium cinnamate, glycyrrhizic acid, glycyrrhetate,
One of which or several arbitrary proportion mixtures may be selected in propionate.
3. auristilla as described in claim 1, it is characterised in that:The auristilla is liquor, the total mass concentration of effective ingredient
For 0.5-20.0%, surplus is solvent;Each composition is in terms of mass fraction in effective ingredient, specially:
The natural anti-inflammatory bacteriostatic agent, is carried by Nantural non-toxic Chinese herbal medicine alcohol extract, Honegsukle flower P.E, chrysanthemum extract, the root of Dahurain angelica
Object, menthol and peppermint oil is taken to constitute, specifically:Nantural non-toxic Chinese herbal medicine alcohol extract 1.0-80.0, Honegsukle flower P.E
0.01-9.0, chrysanthemum extract 0.01-6.0, Angelica Dahurica extract 0.01-6.0, menthol 0.01-10.0, peppermint oil 0.01-
6.0;
The cell physiological function regulator, is made of, specifically vitamins and coenzyme class:
Vitamin V B1 0.01-6.0, vitamin V B2 0.001-1.0, niacinamide 0.01-10.0, VB5 0.01-6.0, VB6
0.01-6.0, niacin 0.01-5.0, Vc 0.01-5.0, Ve 0.001-1.0;
Biotin 0.001-1.0, Co-Q10 0.001-1.0, Coenzyme I 0.001-2.0, Coenzyme I I 0.001-2.0;
The cell-protecting, is made of trehalose and allantoin, specifically:Trehalose 0.01-9.0, allantoin 0.001-
2.0;
The cellular agonist is made of, specifically ATP disodiums and cromoci:ATP disodiums 0.01-5.0, cell color
Plain C 0.001-5.0;
It described promoting blood circulation and removing obstruction in channels dose, is made of Notogineng Extract, notoginseng total saponin/glycosides and VB12, specifically:Notogineng Extract
0.01-10.0, notoginseng total saponin/glycosides 0.001-2.0, VB12 0.01-10.0;
The intelligence hardening agent, be zinc gluconate, zinc lactate, zinc citrate, specifically:Zinc gluconate 0.01-4.0,
Zinc lactate 0.01-4.0, zinc citrate 0.01-4.0;
The antioxidant is taurine, VC sodium, phytic acid, phytate;Specifically:Taurine 0.01-5.0, VC sodium 0.01-
5.0, phytic acid 0.01-5.0, phytate 0.01-5.0;
The required agent of cell normal growth metabolism, is made of, specifically amino acids, lactic acid class and inositol:
Arginine 0.001-5.0, serine 0.001-5.0, glycine 0.001-9.0, glutamic acid 0.001-1.0, glutamine
0.01-8.0, lactic acid 0.01-5.0, sodium lactate 0.01-5.0, sodium glutamate 0.01-3.0;Inositol 0.01-6.0;
The preservative is made of potassium sorbate, dehydroactic acid sodium, potassium cinnamate, glycyrrhizic acid, glycyrrhetate and propionate, tool
For body:It is potassium sorbate 0.01-2.0, dehydroactic acid sodium 0.01-2.0, potassium cinnamate 0.01-2.0, glycyrrhizic acid 0.01-1.0, sweet
Oxalates 0.01-3.0, propionate 0.01-2.0.
4. auristilla according to claim 3, it is characterised in that:The auristilla is liquor, the gross mass of effective ingredient
A concentration of 1.0-18.0%, surplus are water;Each composition is in terms of mass fraction in effective ingredient, specially:
The natural anti-inflammatory bacteriostatic agent, is carried by Nantural non-toxic Chinese herbal medicine alcohol extract, Honegsukle flower P.E, chrysanthemum extract, the root of Dahurain angelica
Object, menthol and peppermint oil is taken to constitute, specifically:Nantural non-toxic Chinese herbal medicine alcohol extract 2.0-76.0, Honegsukle flower P.E
0.01-8.0, chrysanthemum extract 0.01-5.0, Angelica Dahurica extract 0.01-5.0, menthol 0.01-8.0, peppermint oil 0.01-
5.0;
The cell physiological function regulator, is made of, specifically vitamins and coenzyme class:
Vitamin V B1 0.01-5.0, vitamin V B2 0.001-0.5, niacinamide 0.01-8.0, VB5 0.01-5.0, VB6
0.01-5.0, niacin 0.01-4.0, Vc 0.01-4.0, Ve 0.01-1.0;Biotin 0.001-0.60, Co-Q10 0.01-
1.0, Coenzyme I 0.01-1.20, Coenzyme I I 0.01-1.60;
The cell-protecting, is made of trehalose and allantoin, specifically:Trehalose 0.01-6.0, allantoin 0.01-
1.0;
The cellular agonist is made of, specifically ATP disodiums and cromoci:ATP disodiums 0.01-4.0, cell color
Plain C 0.01-4.0;
It described promoting blood circulation and removing obstruction in channels dose, is made of Notogineng Extract, notoginseng total saponin/glycosides and VB12, specifically:Notogineng Extract
0.01-8.0, notoginseng total saponin/glycosides 0.01-1.80, VB12 0.01-8.0;
The intelligence hardening agent, be zinc gluconate, zinc lactate, zinc citrate, specifically:Zinc gluconate 0.01-3.0,
Zinc lactate 0.01-3.0, zinc citrate 0.01-3.0;
The antioxidant is taurine, VC sodium, phytic acid, phytate;Specifically:Taurine 0.01-4.0, VC sodium 0.01-
4.0, phytic acid 0.01-4.0, phytate 0.01-4.0;
The required agent of cell normal growth metabolism, is made of, specifically amino acids, lactic acid class and inositol:Arginine
0.001-4.0, serine 0.001-3.0, glycine 0.001-6.0, glutamic acid 0.01-1.0, glutamine 0.01-5.0, breast
Sour 0.01-3.0, sodium lactate 0.01-4.0, sodium glutamate 0.01-2.0;Inositol 0.01-5.0;
The preservative is made of potassium sorbate, dehydroactic acid sodium, potassium cinnamate, glycyrrhizic acid, glycyrrhetate and propionate, tool
For body:Potassium sorbate 0.01-1.80, dehydroactic acid sodium 0.01-1.80, potassium cinnamate 0.01-1.80, glycyrrhizic acid 0.01-
0.80, glycyrrhetate 0.01-2.0, propionate 0.01-1.80.
5. having the auristilla for the treatment of otitis and the refreshing ear function of clear ear as claimed in claim 4, which is characterized in that the drop ear
The total mass concentration of agent, effective ingredient is 7.0%;Each composition is in terms of mass fraction in effective ingredient, specially:
The natural anti-inflammatory bacteriostatic agent, is carried by Nantural non-toxic Chinese herbal medicine alcohol extract, Honegsukle flower P.E, chrysanthemum extract, the root of Dahurain angelica
Object, menthol and peppermint oil is taken to constitute, specifically:Nantural non-toxic Chinese herbal medicine alcohol extract 40.0, Honegsukle flower P.E 5.0, chrysanthemum
Flower extract 3.0, Angelica Dahurica extract 3.0, menthol 5.0, peppermint oil 3.0;
The cell physiological function regulator, is made of, specifically vitamins and coenzyme class:
Vitamin V B1 5.0, vitamin V B2 0.5, niacinamide 8.0, VB5 4.0, VB6 3.0, niacin 4.0, Vc 1.0, Ve
0.4;Biotin 0.6, Co-Q10 0.6, Coenzyme I 0.8, Coenzyme I I 0.9;
The cell-protecting, is made of trehalose and allantoin, specifically:Trehalose 4.5, allantoin 0.9;
The cellular agonist is made of, specifically ATP disodiums and cromoci:ATP disodiums 4.0 and cromoci
4.0;
It described promoting blood circulation and removing obstruction in channels dose, is made of Notogineng Extract, notoginseng total saponin/glycosides and VB12, specifically:Notogineng Extract
4.0, notoginseng total saponin/glycosides 0.6, VB12 8.0;
The intelligence hardening agent, be zinc gluconate, zinc lactate, zinc citrate, specifically:Zinc gluconate 2.0, zinc lactate
3.0, zinc citrate 1.0;
The antioxidant is taurine, VC sodium, phytic acid, phytate;Specifically:Taurine 1.0, VC sodium 2.0, phytic acid
2.0, phytate 2.0;
The required agent of cell normal growth metabolism, is made of, specifically amino acids, lactic acid class and inositol:
Arginine 4.0, serine 1.0, glycine 8.0, glutamic acid 0.9, glutamine 7.0, lactic acid 4.0, sodium lactate 4.0, paddy
Propylhomoserin sodium 2.0, inositol 4.0;
The preservative is made of potassium sorbate, dehydroactic acid sodium, potassium cinnamate, glycyrrhizic acid, dipotassium glycyrrhizinate and sodium propionate, tool
For body:Potassium sorbate 1.0, dehydroactic acid sodium 0.8, potassium cinnamate 0.8, glycyrrhizic acid 0.5, dipotassium glycyrrhizinate 2.0, sodium propionate 0.9.
6. having the application of the auristilla for the treatment of otitis and the refreshing ear function of clear ear as described in claim 1, which is characterized in that use
Method is:In ear refreshing for otitis or clearly ear, auristilla is instilled by earhole in external auditory canal, is gently massaged by cephalomenia side
A moment.
7. application of the auristilla as claimed in claim 6 in preparing treatment otitis and the refreshing ear function medicament of clear ear, feature exist
In, in terms of dosage, 1-3 drops/time, 1-3 times/day;It is 0.02-0.04mL per drop volume.
8. the preparation method of the auristilla for the treatment of otitis and the refreshing ear function of clear ear as described in claim 1, which is characterized in that tool
Body includes the following steps:
(1)Effective ingredient in auristilla is divided into 4 groups according to material properties and the convenience of preparation and easy property processed, weighs match respectively
Dosage is spare in side, specifically:
First group, glycitols compound;
Second group, amino acids;
Third group, vitamin coenzymes class compound;
4th group, unclassified stores in addition to the solvents;
(2)By step(1)In second group of material weighing be placed in reaction kettle, the solvent of part formulation amount, stirring is then added
Mixing is dissolved, is stood, mixture A is obtained after filtering and impurity removing;
(3)By step(1)In the third group that weighs and the 4th group of material be placed in reaction kettle, the molten of part formulation amount is then added
Agent, stirring and dissolving mixing are stood, and mixture B is obtained after filtering and impurity removing;
(4)By step(3)Mixture B be slowly added into step(2)Mixture A in, after the completion of addition, be added step(1)
In first group of material weighing, be eventually adding the solvent and auxiliary agent of remainder formula ratio, dissolving mixing, filtering and impurity removing are adjusted
PH=3.5 ~ 7.5, this is auristilla product provided herein.
9. having the preparation method of the auristilla for the treatment of otitis and the refreshing ear function of clear ear as claimed in claim 8, which is characterized in that
Step(2), step(3), step(4)In carry out dissolving mixing operation when, operation temperature be not higher than 45 DEG C, be not less than 10 DEG C.
10. the Nantural non-toxic Chinese herbal medicine alcohol extract in natural anti-inflammatory bacteriostatic agent as described in claim 1,3,4,5,8, feature
It is, the component that the Nantural non-toxic Chinese herbal medicine alcohol extract contains following mass fraction is simultaneously made by following processes:Gold
30~90 parts of honeysuckle flower, 40~80 parts of chrysanthemum, 40~75 parts of licorice, 40~75 parts of pueraria lobata, 40~75 parts of Radix Salviae Miltiorrhizae, Radix Astragali 20~55
Part, 30~60 parts of Radix Notoginseng, 10~50 parts of Radix Angelicae Sinensis, windproof 30~70 parts, 15~70 parts of schizonepeta, 20~80 parts of peppermint, the root of Dahurain angelica 15~
50 parts, 15~50 parts of akebi, 15~90 parts of Centipeda minima;Its process of preparing includes:The formula Chinese medicine is weighed, is crushed to
Grain size is the particle of grain of rice size, and a concentration of 10-90% for being equivalent to 5-20 times of quality of mixture is added(V/V)Ethyl alcohol, then
More than a few hours extracting solution is collected by filtration up to described in extraction under the conditions of set temperature is 20-105 DEG C in multi-functional extractor
Alcohol extract.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810853764.3A CN108635572A (en) | 2018-07-30 | 2018-07-30 | It is a kind of to treat otitis and the auristilla and preparation method thereof for ear function of feeling well with clear ear |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810853764.3A CN108635572A (en) | 2018-07-30 | 2018-07-30 | It is a kind of to treat otitis and the auristilla and preparation method thereof for ear function of feeling well with clear ear |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108635572A true CN108635572A (en) | 2018-10-12 |
Family
ID=63760550
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810853764.3A Pending CN108635572A (en) | 2018-07-30 | 2018-07-30 | It is a kind of to treat otitis and the auristilla and preparation method thereof for ear function of feeling well with clear ear |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108635572A (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103007096A (en) * | 2012-12-25 | 2013-04-03 | 臧金文 | Preparation raw materials of dropping liquid for treating rhinitis and tympanitis and production process thereof |
CN104324212A (en) * | 2014-11-25 | 2015-02-04 | 邹士东 | Traditional Chinese medicine composition for treating otitis media combined tinnitus and medical application thereof |
CN104825910A (en) * | 2015-06-04 | 2015-08-12 | 李元庆 | Traditional Chinese medicine preparation for secretory otitis media and its preparation method |
-
2018
- 2018-07-30 CN CN201810853764.3A patent/CN108635572A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103007096A (en) * | 2012-12-25 | 2013-04-03 | 臧金文 | Preparation raw materials of dropping liquid for treating rhinitis and tympanitis and production process thereof |
CN104324212A (en) * | 2014-11-25 | 2015-02-04 | 邹士东 | Traditional Chinese medicine composition for treating otitis media combined tinnitus and medical application thereof |
CN104825910A (en) * | 2015-06-04 | 2015-08-12 | 李元庆 | Traditional Chinese medicine preparation for secretory otitis media and its preparation method |
Non-Patent Citations (2)
Title |
---|
李丽萍: "中西医结合治疗真菌性外耳道炎合并细菌感染30例", 《现代中医药》 * |
王槐富等: "中药耳炎液局部治疗中耳炎疗效总结", 《医学科技》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109106806A (en) | A kind of women secret nursing washing lotion and preparation method thereof | |
WO2017101790A1 (en) | Pharmaceutical composition for treating cutaneous pruritus and use thereof | |
CN113081928B (en) | Plant antibacterial gel and preparation method and application thereof | |
US10478463B2 (en) | External-use medicament for cleaning and care of the ovaries, vagina, and vulva | |
CN102526411B (en) | Chinese medicinal composition for treating surgical wound | |
CN112915055A (en) | Multi-effect mite-killing-relieving composition and application thereof | |
CN110721095B (en) | Herbal oral bacteriostatic spray containing propolis and preparation method thereof | |
CN106727026A (en) | A kind of Chinese medicine acne-removing composition and its application | |
CN102988844A (en) | Gynaecological gel and extraction method thereof | |
CN103721138B (en) | A kind of traditional Chinese medicine for external application and its preparation method treating rosacea | |
US11173101B1 (en) | Silver ion bacteriostatic hand sanitizer and preparation method and application thereof | |
CN108635572A (en) | It is a kind of to treat otitis and the auristilla and preparation method thereof for ear function of feeling well with clear ear | |
CN105326954B (en) | A kind of Chinese medicine composition and preparation method thereof for treating blear-eye | |
CN113181336A (en) | Traditional Chinese medicine composition and preparation for treating gynecological diseases and preparation method and application thereof | |
CN109568486B (en) | Composition with effect of treating conjunctivitis and preparation method thereof | |
CN101757119B (en) | Medicine composition for treating vaginitis as well as gel and preparation method thereof | |
CN108685754A (en) | A kind of auristilla for the ear function that relaxes for tinnitus and with strong ear | |
CN105560763A (en) | Traditional Chinese medicine composition skin disinfectant | |
CN112675085A (en) | Itching-relieving and soothing liquid for skin and preparation method thereof | |
CN105497460A (en) | Disinfectant for disinfecting skins | |
CN105056050A (en) | Plant extract compound suppository for treating gynecological diseases and preparation method thereof | |
CN105943718B (en) | Agilawood compound traditional Chinese medicine composition as well as preparation method and application thereof | |
CN101766731B (en) | Tea polyphenol acne resistant external preparation | |
CN113633717B (en) | Electronic atomized liquid composition for nasal cavity care, application thereof and obtained care product | |
CN108939078A (en) | It is a kind of with treatment tinnitus and the preparation of ear healthcare function and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |